AWARDS & RANKINGS / PRESS RELEASE
McDermott Named Law360 Practice Group of the Year for Health Care for Third Year in a Row
January 22, 2024
Read time: 4 min
January 22, 2024 — International law firm McDermott Will & Emery has once again been named Practice Group of the Year for Health Care by Law360. This is the Firm’s third consecutive year and eighth time overall receiving this honor.
In 2023, McDermott’s healthcare team worked alongside industry leaders across sectors in their most high-stakes matters, including representing Geisinger Health, a $7 billion health provider; health insurer; and medical school, in its acquisition by Kaiser Permanente and representing CVS Health in its definitive agreement to acquire Signify Health, Inc. McDermott is also well-known for its work with healthcare private equity funds and associated portfolio companies, digital health companies, health systems, hospitals, medical groups, physician practice management companies, payors, and life sciences and medical device companies.
“We are honored to be recognized by Law360 as Practice Group of the Year for Health Care for the third year in a row,” said Jerry Sokol, global head of McDermott’s Healthcare Practice Group. “We continuously strive to ensure that our global healthcare practice is well-positioned to represent our clients in their most sophisticated and complex matters, and this prestigious recognition affirms our ability to accomplish that objective.”
McDermott is the nation’s leading healthcare law firm and consistently receives top national rankings from Best Law Firms, Chambers USA, The Legal 500 United States and Law360. McDermott has been ranked as a top healthcare law firm for 14 consecutive years by Chambers USA and was also recognized by Chambers as “Healthcare Team of the Year” in 2010, 2013, 2017, 2019 and 2022 and by Best Law Firms as “Law Firm of the Year for Healthcare” in 2017, 2019, 2020, 2022 and 2024. The Firm has also repeatedly held the top spot in PitchBook’s League Tables as the most active firm for healthcare private equity.
Law360 publishes several award series throughout the year, including those that highlight top-performing lawyers and practice groups. The 2023 Practice Group of the Year hail from 84 law firms and rose to the top of nearly 800 submissions.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact

Schulte Roth & Zabel Represents Wellington Management in $175 Million Investment
PRESS RELEASE
Schulte Roth & Zabel Represents Wellington Management in $175 Million Investment
January 19, 2024
Read time: 2 min
Schulte Roth & Zabel represented Wellington Management in connection with an aggregate $175 million investment in FirstSun Capital Bancorp in a capital raise to support FirstSun’s acquisition of HomeStreet, Inc.
The firm’s M&A and Securities team was led by partners David A. Curtiss and Adriana Schwartz with special counsel Clara Zylberg and associate Rachel DiSciullo.
Media Contact

McDermott Will & Emery Advised Artemid in the First Foundraising of Artemid Senior Loan IV
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Will & Emery Advised Artemid in the First Foundraising of Artemid Senior Loan IV
January 18, 2024
Read time: 3 min
McDermott Will & Emery has advised Artemid, a subsidiary of CAPZA, in the first foundraising of Artemid Senior Loan IV (ASL IV).
The private debt team with €1.4m of assets under management has completed the first closing of the fourth vintage of its €300m senior debt fund. The fund aims to invest between €5m and €50m per transaction, with a fundraising target of €450m to €500m.
Following on from its predecessor funds, ASL IV’s strategy is to invest mainly in tranches B and C of senior debt alongside major French and international banks.
Structured as an “Article 8” SLP, Artemid is committed to placing ESG at the heart of its investment decisions.
The McDermott Will & Emery team that advised Artemid comprised:
Media Contact
McDermott Boosts FDA Practice With Five Lawyer Team
PRESS RELEASE
McDermott Boosts FDA Practice With Five Lawyer Team
January 16, 2024
Read time: 5 min
International law firm McDermott Will & Emery welcomes a new five lawyer US Food and Drug Administration (FDA) team to its Healthcare Practice Group. Joining from Wilson Sonsini Goodrich & Rosati, the team includes Partners James “Jamie” Ravitz and Paul Gadiock and provides strategic counsel to FDA-regulated life sciences, digital health and healthcare services companies and their investors, including private equity. The group also provides critical FDA-related transactional support, leads FDA and healthcare investigations and government enforcement actions, provides FDA and healthcare regulatory general counsel services, and brings novel technologies and products through the FDA regulatory process.
“We have long sought to expand and bolster our existing FDA team by adding industry-leading practitioners like Jamie and Paul,” said Jerry Sokol, global head of Healthcare at McDermott. “FDA regulation is a pressing concern for a rapidly increasing number of our health and life sciences and investor clients, and we’re well positioned to meet all areas of critical need in the FDA space. Their decision to join McDermott reflects our status as a destination for top-tier healthcare lawyers.”
Jamie, who led the FDA, healthcare and consumer products compliance practice at his prior firm, works with clients across the entire spectrum of life sciences and healthcare space, including providing regulatory counsel, enforcement defense, and litigation and compliance guidance. He is particularly focused on FDA and healthcare regulatory counseling and works in partnership with companies and investors to help them achieve their business goals across the complete ecosystem of FDA-regulated products. He has consistently been recognized as a leading lawyer in healthcare and life sciences by publications including Chambers USA, LMG Life Sciences and U.S. News & World Report – Best Lawyers.
“McDermott is a leader in the healthcare space. I’m thrilled to join the Firm and have access to its deep resources and diverse client base to help drive growth for the FDA practice,” Jamie said.
As a former member of senior leadership at the FDA’s Center for Devices and Radiological Health, Paul leverages his firsthand experience at the agency to counsel life sciences, healthcare and other FDA-regulated companies at every phase of the product lifecycle. He is based in San Francisco.
Paul said, “McDermott’s market reputation speaks for itself, and I’m excited to collaborate with new colleagues across the country on medical and consumer product matters.”
Jamie and Paul’s team will include seasoned FDA and healthcare lawyers with significant experience in enforcement and litigation matters, and former US Department of Health and Human Services Office of Inspector General lawyers.
McDermott is the nation’s leading healthcare law firm and the only healthcare practice to receive top national rankings from U.S. News – Best Lawyers “Best Law Firms,” Chambers USA, The Legal 500 US and Law360. The practice was also recognized by Chambers as “Healthcare Team of the Year” in 2010, 2013, 2017, 2019 and 2022. McDermott has also repeatedly held the top spot in PitchBook’s League Tables as the most active firm for healthcare private equity.
“As a regulatory quarterback, Jamie will be a great addition to our team. And adding Paul in San Francisco allows us to extend our already robust FDA practice coast to coast,” said Doug Carsten, global head of McDermott’s global Life Sciences Practice Group. “I’m looking forward to working with this group to solve some of the most important challenges our clients face.”
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact

McDermott Represents Constellation Brands in $400 Million Senior Notes Offering
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Represents Constellation Brands in $400 Million Senior Notes Offering
January 11, 2024
Read time: 3 min
International law firm McDermott Will & Emery represented Constellation Brands, Inc. (Constellation Brands), a leading beverage alcohol company, in its SEC-registered offering of $400 million aggregate principal amount of 4.800% Senior Notes due 2029.
Constellation Brands is an international producer and marketer of beer, wine and spirits with operations in the US, Mexico, New Zealand and Italy. Constellation’s brand portfolio includes Corona Extra, Modelo Especial, the Robert Mondavi Brand Family, Kim Crawford, Meiomi, The Prisoner Wine Company, High West, Casa Noble and Mi CAMPO.
The McDermott deal team was led by Heidi Steele and included Sunyi Snow, Glen Ready, Marisa Montoya and Dan Zucker.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact

Schulte Roth & Zabel Launches Alumni Network
PRESS RELEASE
Schulte Roth & Zabel Launches Alumni Network
January 9, 2024
Read time: 3 min
Schulte Roth & Zabel is proud to announce the launch of the Schulte Alumni Network, a central hub that will connect the firm’s past and present lawyers and business professionals by providing a platform to share ideas, tell stories, ask questions and build relationships through a range of activities, experiences and content.
At the heart of Schulte’s Alumni Network is a new members-only portal that will feature a directory, firm and alumni news, spotlights, a calendar of social events, thought leadership, career opportunities and many other features.
“Since our firm’s inception 54 years ago, successive generations of our people have been an integral part of their industries and communities, both as Schulte employees and as they move to roles in other organizations,” said David Efron, co-managing partner of Schulte. “While we have always been in close contact with our nearly 3,500 alumni, this peer-to-peer network optimizes their ability to maintain connections, find mentors and mentees, and keep up with the latest business and legal trends and developments.”
“We are excited about how this network will build upon and elevate what is already a vibrant and thriving alumni community,” said Marc Elovitz, co-managing partner of Schulte. “So many of our colleagues and friends have gone on to accomplish great things and become leaders in their fields. Staying connected to them is key to our vision and values.”
Media Contact

McDermott Represents BPD in its Acquisition of Revive Marketing
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Represents BPD in its Acquisition of Revive Marketing
January 8, 2024
Read time: 3 min
International law firm McDermott Will & Emery represented BPD, the premier data-driven health system marketing services company in the United States and portfolio company of private equity firm WindRose Health Investors, LLC (WindRose), in its platform acquisition of Revive Marketing, LLC (Revive), a marketing agency which offers brand, marketing, advertising and communications solutions.
BPD is a pioneer in hospital marketing and has a client roster of more than 250 hospitals. WindRose makes equity investments in companies that operate within the services sectors of the healthcare industry. The combination forms a marketing and communications tech-enabled services organization serving the nation’s leading hospital, health system and care delivery brands, as well as notable clients from the health tech, health services and overall healthcare space.
The McDermott deal team was led by Jed Spielman, Jarrett Szczesny and Nic Dilts, with significant assistance from Kate McDonald, Monica Wallace, Denise Burke, Gregory Mitchell, Caroline Reignley, Adam Marks, Karen Gibbs, Grayson Dimick, Alex Ruiz, Dino Ilievski, Scott Weinstein, Abigail Kagan, Cristell Fortune, Kate Williams, Lisa Loesel, Jennifer Hill, Sarah Bro, Maxwell Preston, Raja Chaterjee and Mark Bilut.
The McDermott finance team included Josh Samis, John Parker, Daniel Mayor and Aileen Requejado.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact

McDermott Assists Claris Ventures in EUR 6.9m Investment Round in ALKemist Bio
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Assists Claris Ventures in EUR 6.9m Investment Round in ALKemist Bio
January 2, 2024
Read time: 3 min
International law firm McDermott Will & Emery assisted Claris Ventures in an EUR 6.9 million investment round in ALKemist Bio to support a TCR cellular therapy for the ultimate generation of positive ALK tumors.
Claris Ventures SGR SpA makes equity investments in early-stage biopharma companies with a clear vision and solid scientific evidence.
ALKemist is a pioneering biotech company born from the research of Professor Roberto Chiarle, dedicated to developing cellular immunotherapies for patients with ALK-positive tumors.
The McDermott team advising Claris Ventures was led by Milan-based corporate partner Ettore Scandale, supported by associate Carlo Lemmi and trainee Carlo Serranò.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact

McDermott Represents Grupo Mexico Transportes in 60% Equity Stake Acquisition from Genesee & Wyoming Inc. and SEACOR Holdings Inc.
DEAL ANNOUNCEMENT / PRESS RELEASE
McDermott Represents Grupo Mexico Transportes in 60% Equity Stake Acquisition from Genesee & Wyoming Inc. and SEACOR Holdings Inc.
January 4, 2024
Read time: 4 min
International law firm McDermott Will & Emery represented Grupo Mexico Transportes (GMXT) in the acquisition of a 60% equity stake from Genesee & Wyoming Inc. (G&W) and SEACOR Holdings Inc. (SEACOR) of:
- The joint venture that owns and operates CG Railway, a company that provides 4-day rail-ferry service between the ports of Mobile, Alabama, and Coatzacoalcos, Veracruz, across the Gulf of Mexico.
- The joint venture that owns two double-deck 590-foot roll-on/roll-off rail ferries used in such rail-ferry service.
GMXT is the largest railroad transportation company with the greatest coverage in Mexico. It offers general hauling and intermodal services by railroad, ancillary terminal management and interterminal hauling. G&W will remain as a partner of GMXT, holding 40% of the equity of the joint ventures. The transaction is still subject to regulatory approval by the US authorities.
The McDermott deal team was led by Howard Kleinman and included Carla Tomazella, Mateus Camarotti and Kathy Schumacher.
Read G&W’s announcement.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
Media Contact

Schulte Roth & Zabel Elects Six New Partners and Promotes Seven to Special Counsel
PRESS RELEASE
Schulte Roth & Zabel Elects Six New Partners and Promotes Seven to Special Counsel
January 4, 2024
Read time: 8 min
Schulte Roth & Zabel is pleased to announce that William Barbera, Sean Brownridge, Andrew Gladstein, Robert Griffin, Theodore Keyes and Donna Lazarus were elected to the firm’s partnership effective January 1, 2024. All are resident in the New York office.
The firm is also pleased to announce the promotion of Mark Garibyan, Farzaan Ijaz, Kolby Loft, Andrew Mazzarella, Ryan Post, Gregory Springsted and Shannon Wolf to special counsel. All are resident in the New York office with the exception of Ijaz, who is based in Washington, DC.
“We’re proud to recognize the accomplishments and potential of these attorneys who have the insight, creativity and focus that define Schulte Roth & Zabel,” said David Efron, co-managing partner of the firm. “Their capabilities and experience reflect the diversity of service our clients demand.”
“The specialized expertise of our newly promoted partners and special counsel is particularly impressive,” said Marc Elovitz, co-managing partner of Schulte. “Their leadership will be key to their success, and we look forward to their continued achievements.”
Partners
William J. Barbera focuses his practice on transactional and regulatory matters impacting broker-dealers, hedge funds and other financial institutions. He advises clients regarding a number of regulations applicable to securities trading and custody practices, including regulations related to alternative trading systems, short sale practices, best execution obligations, trading in new issues and the SEC’s customer protection rule. Bill also advises clients on transactional matters, including mergers and acquisitions involving broker-dealers and the negotiation of trading, custody and prime brokerage agreements. He received his J.D., cum laude, from Washington University School of Law, his M.B.A. from Washington University, Olin School of Business and his B.A., cum laude, from Tufts University.
Sean W. Brownridge counsels investors on shareholder activism, corporate governance, M&A, and securities law matters. His practice focuses on investment execution, shareholder engagement, negotiated settlements, proxy contests, and contested M&A transactions. Sean’s experience also includes advising public company boards of directors and management teams on activism preparedness and defense. He previously served as the law clerk to the Honorable Karen L. Valihura of the Delaware Supreme Court. Sean received a J.D. from the University of Pennsylvania Law School, where he was awarded the Oscar Bregman Prize for Excellence in the Field of Business Law, a Certificate of Management from The Wharton School, and a B.G.S, with high distinction, from the University of Michigan.
Andrew D. Gladstein has extensive experience representing investment managers and alternative investment funds, including hedge and private equity funds, in a wide variety of complex commercial litigations, regulatory actions and investigations, and arbitrations. Andy has successfully litigated numerous high-stakes private placement disputes, and routinely advises clients engaged in shareholder disputes, including shareholder activist matters. He received his J.D. from the Benjamin N. Cardozo School of Law at Yeshiva University where he was a recipient of the Jacob Burns Medal for outstanding student achievement, and his B.A. with high honors in government & politics from the University of Maryland.
Robert E. Griffin concentrates his practice on complex commercial litigation on behalf of investment managers, private investment funds, financial institutions, private companies and individuals, including a broad range of business disputes involving claims for breach of fiduciary duty, breach of contract, fraud, and other commercial torts. Robert also has significant experience representing and advising investment managers and private investment funds in complex litigation arising out of life settlement investments. He received his J.D. from Columbia Law School and his B.A. from the University of Notre Dame.
Theodore A. Keyes practices in the specialty areas of environmental law and insurance law in connection with transactions and litigation. For more than two decades, Ted has advised prominent corporations, private equity firms, investment managers, lenders, insurance companies and other entities. His environmental practice focuses on environmental, health and safety risks associated with domestic and international mergers and acquisitions, financings, real estate, and other transactions as well as environmental insurance coverage cases, cost recovery actions and regulatory matters. Ted’s insurance practice includes advising policyholders with respect to specialty insurance products such as representations and warranties insurance and judgment preservation policies as well as in connection with management liability policy issues. His litigation practice covers a wide range of issues and disputes involving insurance and environmental law in state and federal court, as well as in the context of alternative dispute resolution. He received his J.D. from the Fordham University School of Law and his B.A. in Political Communications from George Washington University.
Donna K. Lazarus handles employment discrimination and labor relations matters and advises clients on hiring, managing, and terminating employees in compliance with federal, state and local laws. Donna advises clients on harassment and discrimination matters, and assists with drafting employment-related policies. She also works with a broad range of educational institutions, including independent schools, colleges, universities, professional training programs and education-related associations, advising them on a variety of legal matters, including board liability, student discipline, learning and other disabilities, employment matters, harassment and bullying, admissions, contracts and litigation issues. She received her J.D. from New York University and her B.A., summa cum laude in Philosophy, Politics, and Law from Binghamton University.
Special Counsel
Mark L. Garibyan practices in the areas of commercial, business and bankruptcy disputes, as well as shareholder activism litigation. His practice also includes internal and government investigations relating to federal securities laws, anti-money laundering and Foreign Corrupt Practices Act issues. He received his J.D., cum laude from the University of Michigan and his B.A., cum laude from Brandeis University.
Farzaan Ijaz practices in the firm’s Finance & Derivatives Group and focuses his practice on representing hedge funds, asset managers and private equity funds and their portfolio companies as borrowers and lenders in a wide variety of financing transactions. He has particular expertise in leveraged finance transactions and fund finance, including acquisition financings, capital call facilities, asset-based and cash-flow facilities, mezzanine and subordinated loans, NAV facilities, carried interest and management company financings, rated feeders, cross-border transactions and other complex credit arrangements. He received his J.D. from New York University and his B.B.A., magna cum laude in Finance from Texas Tech University.
Kolby K. Loft represents private funds, broker-dealers, and other financial institutions in enforcement proceedings and investigations by the SEC, DOJ, FINRA, self-regulatory organizations and state regulators. Kolby has advised clients during investigations and enforcement matters relating to potential insider trading, securities fraud, market manipulation, and a wide array of investment adviser and broker-dealer rules and regulations. He also represents clients in regulatory investigations relating to developing financial technologies, including digital assets. Kolby previously worked at global law firms and in the litigation department of a global investment bank. He received his J.D. and his B.A., cum laude from New York University.
Andrew M. Mazzarella focuses his practice on the representation of private funds (including hedge funds, private equity funds, hybrid funds and funds of funds) and investment advisers in connection with their structuring, formation and ongoing operational needs, and on regulatory and compliance matters. He received his J.D. from Fordham University and his B.A. from the College of the Holy Cross.
Ryan A. Post practices in the firm’s M&A and Securities group. He received his J.D., cum laude from Seton Hall University and his B.A., magna cum laude from American University.
Gregory R. Springsted practices in the firm’s Litigation group. He received his J.D. from New York University and his B.S. from the University of Richmond.
Shannon B. Wolf practices in the firm’s Litigation and Enforcement group. She received her J.D. from the University of Connecticut and her B.A. from Western Connecticut State University.